Previous Close | 1.5100 |
Open | 1.5200 |
Bid | 1.4600 x 0 |
Ask | 1.5000 x 0 |
Day's Range | 1.4700 - 1.5500 |
52 Week Range | 1.3900 - 2.2000 |
Volume | |
Avg. Volume | 63,676 |
Market Cap | 209.504M |
Beta (5Y Monthly) | 0.96 |
PE Ratio (TTM) | 64.35 |
EPS (TTM) | 0.0230 |
Earnings Date | Nov 22, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.79 |
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Revenues up 22% to $14.1 million; Adjusted EBITDA up 9% to $2.5 millionBEVERLY, Mass. and TORONTO, May 19, 2022 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported financial and operational results for the quarter-ended March 31, 2022. Highlights Sales in USD increased 22% year over year to $14.1 million; sales in co
BEVERLY, Mass. and TORONTO, May 11, 2022 (GLOBE NEWSWIRE) -- In a press release issued earlier today by Hamilton Thorne Ltd. (TSX-V: HTL), we were informed the headline of the release should read "Hamilton Thorne to Announce Q1 2022 Financial Results and Hold Conference Call on May 19, 2022" instead of "Hamilton Thorne to Announce Q4 and Year End 2021 Financial Results and Hold Conference Call on May 19, 2022". Complete corrected text follows. Hamilton Thorne to Announce Q1 2022 Financial Result